Updates

Calnex Solutions

September 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Calnex has said Q1 trading is in-line. Its Lab Sync platform, Paragon-Neo, has had encouraging levels of pre-orders ahead of launch later in the year. Having hung fire since June, the shares have spiked on the news but look up with events for the moment as LFL comparisons get tougher. Tipped at 68p in December ‘20, hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Volex - Earnings accretive US defence acquisition

D4T4 Solutions

Calnex (April 2023)

Calnex (December 2022)

Calnex - Strong sales momentum continues (July 2022)

Calnex (January 2022)

Calnex (November 2021)

Calnex (June 2021)

Calnex Solutions - Calnex Shares climb 143% in only two months! (January 2021)

Calnex Solutions - Neo beats expectations for 6 quarters (December 2020)

Calnex Solutions - 5G testing specialist (November 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X